JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DM
1551
DELISTED
Dominion Energy Midstream Ptr LP
DM
| $19.4M | ﹤0.01% |
638,504
-296,960
| -32% | -$9.34M |
|
1552
SS&C Technologies
SSNC
$18.7B
| $19.4M | ﹤0.01% |
479,521
+110,454
| +30% | +$4.5M |
|
1553
EPR Properties
EPR
$4.63B
| $19.3M | ﹤0.01% |
294,228
-62,592
| -18% | -$4.28M |
|
1554
Cboe Global Markets
CBOE
$29.8B
| $19.2M | ﹤0.01% |
154,446
+22,782
| +17% | +$2.67M |
|
1555
CALL
BCE
BCE
$21B
| $19.2M | ﹤0.01% |
400,000
+100,000
| +33% | +$4.76M |
|
|
HR
1556
DELISTED
Healthcare Realty Trust Incorporated
HR
| $19.2M | ﹤0.01% |
596,976
-28,121
| -4% | -$913K |
|
1557
iShares MSCI China ETF
MCHI
$6.42B
| $19.2M | ﹤0.01% |
288,057
+77,335
| +37% | +$5.11M |
|
1558
CarMax
KMX
$8.34B
| $19.1M | ﹤0.01% |
297,871
+143,954
| +94% | +$10.3M |
|
1559
Alerian MLP ETF
AMLP
$13.3B
| $19.1M | ﹤0.01% |
353,723
+4,161
| +1% | +$223K |
|
1560
iShares MSCI Taiwan ETF
EWT
$11B
| $19.1M | ﹤0.01% |
526,505
+287,736
| +121% | +$10.7M |
|
|
MSFG
1561
DELISTED
MainSource Financial Group Inc
MSFG
| $19.1M | ﹤0.01% |
524,918
-1,097
| -0.2% | -$41.1K |
|
|
KW
1562
DELISTED
Kennedy-Wilson Holdings
KW
| $19M | ﹤0.01% |
1,096,278
+939,693
| +600% | +$17.7M |
|
1563
CALL
Nike
NKE
$62.5B
| $19M | ﹤0.01% |
303,900
-11,600
| -4% | -$667K |
|
1564
PUT
Snap
SNAP
$9.05B
| $19M | ﹤0.01% |
+1,299,400
| New | +$18.9M |
|
|
OA
1565
DELISTED
Orbital ATK, Inc.
OA
| $18.9M | ﹤0.01% |
144,005
-389,728
| -73% | -$51.7M |
|
1566
iShare MSCI Eurozone ETF
EZU
$9.88B
| $18.9M | ﹤0.01% |
435,318
-23,959
| -5% | -$1.04M |
|
1567
Natural Resource Partners
NRP
$1.39B
| $18.8M | ﹤0.01% |
724,081
+25,643
| +4% | +$652K |
|
1568
Charles River Laboratories
CRL
$13.2B
| $18.8M | ﹤0.01% |
171,683
+2,291
| +1% | +$249K |
|
|
HCR
1569
DELISTED
Hi-Crush Inc. Common Stock
HCR
| $18.8M | ﹤0.01% |
1,755,707
+1,584,416
| +925% | +$15.9M |
|
|
MDCO
1570
PUT
DELISTED
Medicines Co
MDCO
| $18.8M | ﹤0.01% |
+687,000
| New | +$21.2M |
|
1571
Deluxe
DLX
$1.12B
| $18.8M | ﹤0.01% |
244,344
-119,336
| -33% | -$8.6M |
|
|
ROIC
1572
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $18.7M | ﹤0.01% |
939,655
+152,657
| +19% | +$2.93M |
|
1573
CALL
Adient
ADNT
$1.44B
| $18.7M | ﹤0.01% |
238,200
+158,200
| +198% | +$12.8M |
|
1574
JPMorgan Diversified Return US Mid Cap Equity ETF
JPME
$476M
| $18.7M | ﹤0.01% |
294,099
-227,037
| -44% | -$14.2M |
|
1575
PUT
Lennar Class A
LEN
$20.6B
| $18.7M | ﹤0.01% |
305,561
+898
| +0.3% | +$51K |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.